Title |
Collagen cross-linking: when and how? A review of the state of the art of the technique and new perspectives
|
---|---|
Published in |
Eye and Vision, November 2015
|
DOI | 10.1186/s40662-015-0030-6 |
Pubmed ID | |
Authors |
Leonardo Mastropasqua |
Abstract |
Since the late 1990s corneal crosslinking (CXL) has been proposed as a new possibility to stop progression of keratoconus or secondary corneal ectasia, with the promising aim to prevent progressive visual loss due to the evolution of the pathology and to delay or avoid invasive surgical procedures such as corneal transplantation. The possibility of strengthening corneal tissue by means of a photochemical reaction of corneal collagen by the combined action of Riboflavin and ultraviolet A irradiation (UVA), radically modified the conservative management of progressive corneal ectasia. This is a review of the state of the art of CXL, reporting basic and clinical evidence. The paper describes basic principles, advantages and limits of different CXL techniques and possible future evolution of the procedure. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Indonesia | 1 | <1% |
Israel | 1 | <1% |
United States | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 127 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 18 | 14% |
Student > Bachelor | 16 | 12% |
Researcher | 14 | 11% |
Other | 12 | 9% |
Student > Ph. D. Student | 11 | 8% |
Other | 28 | 21% |
Unknown | 32 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 58 | 44% |
Biochemistry, Genetics and Molecular Biology | 7 | 5% |
Engineering | 6 | 5% |
Nursing and Health Professions | 5 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
Other | 13 | 10% |
Unknown | 38 | 29% |